at7AM

← The Daily Five · Shared story

Share

Isomorphic Labs raises €4.5 billion to speed AI drug discovery toward clinical trials

Isomorphic Labs, spun out of Google's DeepMind, has secured €4.5 billion ($5 billion) in a Series C funding round co-led by Greenoaks and Sequoia Capital, with significant investment from Alphabet and Andreessen Horowitz. The funding aims to accelerate AI-driven scientific breakthroughs in medicine design and development, with plans to advance promising drug candidates into clinical testing phases.

Why it matters

This funding boost enables Isomorphic Labs to rapidly develop AI-discovered drugs, potentially shortening the timeline for new treatments to reach patients and impacting healthcare innovation worldwide.

Discussion

Loading discussion…

Anyone can vote. Approved members can comment. Log in

Go beyond the Daily Five.

Join for free to explore more stories and take part in the community.

Anyone can vote. Commenting requires approval after registration; creating an account does not grant immediate commenting access.

Join at7AM for free →